Whole-body hyperthermia at the DGHT conference in Berlin

 

www.hyperthermie-kongress.de
 

DGHT-Kongress 1
Dr. Sebastian Zschaeck, from Charité University Berlin, Department of Radiooncology, reviewed the clinical data of fever-range WBH, emphasizing the need for more clinical studies, also planned at Charité University. He reported preliminary results of the ongoing study Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer.
 
DGHT-Kongress 1
Dr. Stefan Hiller and Brigitte Deckers, from Filderklinik near Stuttgart, gave an overview of the principles of integrative oncology in an anthroposophic hospital and reported their use of fever-range whole-body hyperthermia. It is used in palliative, as well as in adjuvant settings, usually approximately 1 treatment per month. Main aims are the mitigation of side-effects of chemotherapy and the stimulation of anti-cancer immune surveillance.
 
DGHT-Kongress 1
Dr. Kay-U. Hanusch, from Emmenspital, in Switzerland reported a systematic review of 7 studies and 148 subjects on The impact of whole-body hyperthermia interventions on mood and depression, published OPEN ACCESS in the International Journal of Hyperthermia Volume 36, 2019 - Issue 1
 

Print Email


heckel medizintechnik GmbH

Olgastrasse 25
73728 Esslingen

Tel: ++49 (0)711 - 128989 - 0
Fax: ++49 (0)711 - 128989 - 20

info@heckel-medizintechnik.de

 

Visit us on Facebook
 

Visit us on Linkedin

 

PARTNER OF

hydrosun

>

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.